Glycemic outcomes of children 2–6 years of age with type 1 diabetes during the pediatric MiniMed ™ 670G system trial

At-home MiniMed™ 670G Auto Mode use by young children safely improved glycemic outcomes compared to two-week open-loop Manual Mode use. The improvements are similar to those observed in older children, adolescents and adults with T1D using the same system for the same duration of time.